Impact of rifampicin-inhibitable transport on the liver distribution and tissue kinetics of erlotinib assessed with PET imaging in rats

Imaging techniques to study drug transporter function in vivo

(2018) Nicolas Tournier et al.   PHARMACOLOGY & THERAPEUTICS

Enterohepatic Circulation Effect in Physiologically Based Pharmacokinetic Models: The Sorafenib Case

(2017) Roberto Andrea Abbiati et al.   INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH

Imaging Probes and Modalities for the Study of Solute Carrier O (SLCO)-Transport Function In Vivo

(2017) Solène Marie et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Potential Drug Interactions Mediated by Renal Organic Anion Transporter OATP4C1

(2017) Toshihiro Sato et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake

(2016) M. Masud Parvez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Inhibitory Interaction Potential of 22 Antituberculosis Drugs on Organic Anion and Cation Transporters of the SLC22A Family

(2016) M. Masud Parvez et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Impact of Membrane Drug Transporters on Resistance to Small-Molecule Tyrosine Kinase Inhibitors

(2016) Claudia Neul et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Molecular Imaging of Membrane Transporters’ Activity in Cancer: a Picture is Worth a Thousand Tubes

(2015) Aniv Mann et al.   AAPS Journal

Management of dose variability and side effects for individualized cancer pharmacotherapy with tyrosine kinase inhibitors

(2015) Tomohiro Terada et al.   PHARMACOLOGY & THERAPEUTICS

The effect of rifampicin, a prototypical CYP3A4 inducer, on erlotinib pharmacokinetics in healthy subjects

(2014) Marta Hamilton et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

PET Imaging of Oatp-Mediated Hepatobiliary Transport of [11C] Rosuvastatin in the Rat

(2014) Jiake He et al.   MOLECULAR PHARMACEUTICS

Transporters in Drug Development and Clinical Pharmacology

(2013) K M Giacomini et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

International Transporter Consortium Commentary on Clinically Important Transporter Polymorphisms

(2013) K M Giacomini et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The SLCO (former SLC21) superfamily of transporters

(2013) Bruno Hagenbuch et al.   MOLECULAR ASPECTS OF MEDICINE

Development of [11C]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status

(2012) I. Bahce et al.   CLINICAL CANCER RESEARCH

Classification of Inhibitors of Hepatic Organic Anion Transporting Polypeptides (OATPs): Influence of Protein Expression on Drug–Drug Interactions

(2012) Maria Karlgren et al.   JOURNAL OF MEDICINAL CHEMISTRY

Pharmacogenetics ofEGFRin lung cancer: perspectives and clinical applications

(2012) Clara Mayo et al.   PHARMACOGENOMICS

OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies

(2011) Megan Roth et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Involvement of Organic Anion Transporting Polypeptide in the Hepatic Uptake of Telmisartan in Rats: PET Studies with [11C]Telmisartan

(2011) Tadayuki Takashima et al.   MOLECULAR PHARMACEUTICS

Membrane transporters in drug development

(2010)   NATURE REVIEWS DRUG DISCOVERY

Elucidating Rifampin's Inducing and Inhibiting Effects on Glyburide Pharmacokinetics and Blood Glucose in Healthy Volunteers: Unmasking the Differential Effects of Enzyme Induction and Transporter Inhibition for a Drug and Its Primary Metabolite

(2008) HX Zheng et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice

(2008) S. Marchetti et al.   MOLECULAR CANCER THERAPEUTICS